Solid Biosciences (SLDB) Invested Capital (2017 - 2024)
Historic Invested Capital for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $170.4 million.
- Solid Biosciences' Invested Capital rose 1805.27% to $170.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $170.4 million, marking a year-over-year increase of 1805.27%. This contributed to the annual value of $126.5 million for FY2023, which is 4024.5% down from last year.
- As of Q3 2024, Solid Biosciences' Invested Capital stood at $170.4 million, which was up 1805.27% from $193.2 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Invested Capital ranged from a high of $253.0 million in Q1 2021 and a low of $22.2 million during Q3 2020
- In the last 5 years, Solid Biosciences' Invested Capital had a median value of $170.4 million in 2024 and averaged $161.5 million.
- Its Invested Capital has fluctuated over the past 5 years, first plummeted by 7951.53% in 2020, then surged by 90473.66% in 2021.
- Quarter analysis of 5 years shows Solid Biosciences' Invested Capital stood at $132.1 million in 2020, then skyrocketed by 57.63% to $208.2 million in 2021, then grew by 1.66% to $211.7 million in 2022, then plummeted by 40.25% to $126.5 million in 2023, then skyrocketed by 34.74% to $170.4 million in 2024.
- Its Invested Capital stands at $170.4 million for Q3 2024, versus $193.2 million for Q2 2024 and $210.7 million for Q1 2024.